Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The interventional oncology devices market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of almost 9%, as per The Business Research Company’s market report!

Read More On The Interventional Oncology Devices Market Report 2022 – https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

The Interventional Oncology Devices Market Size In 2022 And Forecast

The global interventional oncology devices market is expected to reach from $1.97 billion in 2021 to $2.15 billion in 2022 at a compound annual growth rate (CAGR) of 9.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The interventional oncology devices market is expected to grow to $3.03 billion in 2026 at a CAGR of 8.9%.

The market for interventional oncology devices comprises the sale of interventional oncology devices and related services by the entities that manufacture them.

Request for A Sample Of The Global Interventional Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

Availability Of Private And Government Funding Is Driving The Growth Of The Interventional Oncology Devices Market

The American Cancer Society, the largest non-government, not-for-profit cancer research funder, has awarded 93 grants which totaled $40 million in the first of two cycles for 2019 for cancer research. In 2019, the US Congress provided NCI with an amount of $5.74 billion and an additional $400 million for the Cancer Moonshot program that has a special focus on early detection of cancer using the latest technologies. BioProtect Ltd, an Israeli company that develops novel bioabsorbable polymer spacer balloons, received a funding of $13 million of its Series D equity financing from a leading global syndicate of venture investors that finances the ongoing multicenter FDA clinical trial of BioProtect’s lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy. Endosight, the first augmented-reality-guided ablative system, has received 20% of its funding from private organizations. The funding from government and private organizations helps in the development of new technologies and devices, thereby driving the interventional oncology devices market.

Competitive Landscape And The Regional Analysis Of The Interventional Oncology Devices Market

Major players in the interventional oncology devices market are Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Merit Medical Systems Inc, Philips Volcano, AngioDynamics Inc, GE Healthcare, Siemens Healthineers, Sirtex Medical, and Cook Medical Incorporated.

Additionally, as per TBRC’s research – North America was the largest region in the interventional oncology devices market in 2021 holding the largest market share.

The Interventional Oncology Devices Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the interventional oncology devices market.

Deploying Robotics Technology – A Key Trend In The Interventional Oncology Devices Market

The robotic system integrates image-based planning and navigation with the installation of different instruments to the desired body part with better accuracy and efficiency.

Interventional Oncology Devices Market Segmentation By The Business Research Company

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By Procedure: Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Here Are Some Reports Related To The Interventional Oncology Devices Market –

Oncology Devices Global Market Report 2022

Tumor Ablation Therapy Devices Global Market Report 2022

Clinical Oncology Next Generation Sequencing Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found This Article Helpful? Share It On: